期刊
FEBS LETTERS
卷 567, 期 1, 页码 63-66出版社
WILEY
DOI: 10.1016/j.febslet.2004.02.091
关键词
immunosurveillance; tumour immunology; immune escape; immunotherapy of cancer
Tumours are immunogenic and are commonly infiltrated by anti-cancer effector cells. Why, then, are they not completely rejected by the host? Unfortunately, tumours are Darwinian paragons, winning the battle against the forces of natural immune selection. Some of the latter can even act as double-edged swords, actually being subverted to become protumorigenic. Prevention or reserval of tumour escape from the immune response therefore offers the possibility of reconstructing effective anti-tumour immunity and remains the major challenge for 21st century tumour immunology. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据